Embed Size (px)
Citation preview
COMPANY UPDATEPT ENSEVAL PUTERA MEGATRADING TBK.
Ended Sept 30, 2016 (Unaudited)
Passion For Excellence:
Strengthen our Resources to
Create Sustainability
TABLE OF CONTENT
SECTION 1 ENSEVAL IN BRIEF 3
SECTION 2 BUSINESS OVERVIEW 8
SECTION 3 OPERATIONAL OVERVIEW 20
SECTION 4 FINANCIAL OVERVIEW 23
SECTION 5 2016 OVERVIEW 28
SECTION 1ENSEVAL IN BRIEF
ENSEVAL IN BRIEF
• Established in October 1973 with the aim of managing the distribution function because of theseparation of the distribution division from the marketing and production division of PT KalbeFarma;
• On 1 August 1994, the Company listed its shares on the Jakarta Stock Exchange;• The Company focuses its activities on distribution and trading services under 5 divisions:
• Pharmaceutical products sales and distribution, which comprised of patented medicines aswell as generic medicines;
• Consumer products, non prescription medicine and nutrition sales and distribution;• Medical equipment sales and distribution, which include marketing activities;• Raw material sales and distribution, which include veterinary product;• Healthcare services.
Integrated healthcare Distribution and Logistic services company through Service Excellence, Technology Driven and Strong Leadership.
4
1973 – Incorporationof PT Enseval
1988 – Incorporationof PT Arya GuptaCempaka
1993 – PT Arya GuptaCempaka changed its name toPT Enseval PuteraMegatrading
1994 – PT Enseval PuteraMegatrading Tbk conductedits Initial Public Offering
2003 – Incorporationof PT MilleniaDharma Insani
2007 – Incorporation of PTEnseval Medika Prima andPT Global ChemindoMegatrading
2008 – Incorporation of PTRenalmed Tiara Utama
2011 – The CompanyRight Issue to financeexpansion
2012 – Obtained ISO9001:2008certification
2014 – Incorporation of PT Medika Renal Citraprima.
More than 40 years in business, Enseval constanly makes the best effort to obtain sustainable growth.
ENSEVAL IN BRIEF
5
ENSEVAL IN BRIEF
• Currently, the Company owns and operates 46 branches and 27 branches under subsidiaries, and 30sales offices located on Indonesia archipelago;
• The Company also owns 2 Regional Distribution Centers (RDC) located in Jakarta and Surabaya;• For the information technology platform, the Company now is using Oracle E-Business Suite Release 12;• Until the end of September 2016, the Company's operation supported by over than 5,700 employees.
Become Market Leader Through high quality of information Technology systemand competent human resources.
6
AWARDS UNTIL SEPTEMBER 2016
2016 OVERVIEW
• INDONESIAN HUMAN CAPITAL STUDY 2016
• FRONTIER - The Best Building and Managing Corporate Image.– PHARMACEUTICAL DISTRIBUTOR.
– MEDICAL EQUIPMENT DISTRIBUTOR.
• ORACLE - EXA Trend-Setter Award.
• FROST & SULLIVAN - Indonesia Pharmaceutical Distributor of the year.
• Department of Animal Husbandry in East Java province - the best distributor of veterinary drug.
• HERMINA HOSPITAL GROUP - The Best Pharmaceutical Distributor.
• BETHESDA HOSPITAL YOGYAKARTA - The Best Pharmaceutical Distributor.
• NIVEA - The Best Weighted Distributor.
• Rekor Bisnis Indonesia - Pharmaceutical Distributor with the Most Outlet Coverage.
• The Most Powerful Distribution Performance– EXTRA JOSS
– KOMIX
7
• AZ/NZS ISO 9001:2008 Certified
• BS OHSAS 18001:2007 Certified
• Good Distribution Practices Certified (GDP)
• Cara Distribusi Obat yang Baik (CDOB Certified)
SERTIFICATION
2016 OVERVIEW
8
SECTION 2BUSINESS OVERVIEW
*Description of net sales per products as describe below :
BUSINESS OVERVIEW
NET SALES PER PRODUCTS UNTIL SEPTEMBER 30, 2016
Products Portfolio Net Sales (Rp)Contribution to Total Net Sales
Consumer Products 6.070.637.256.423 43,55%
Prescription Medicine 3.743.517.742.077 26,85%
Non Prescription Medicine 2.259.833.128.339 16,21%
Raw Materials for Sale 1.056.189.703.284 7,58%
Medical Equipment 779.445.923.756 5,59%
Veterinary Products 25.197.432.294 0,18%
Health Care Services 5.335.782.616 0,04%
Total : 13.940.156.968.789 100,00%
10
BUSINESS OVERVIEW
DESCRIPTION OF NET SALES PER PRODUCTS AND THE CONTRIBUTION
43,55%26,85%
16,21%
7,58%
5,59% 0,18% 0,04%Consumer Products
Prescription Medicine
Non Prescription Medicine
Raw Materials for Sale
Medical Equipment
Veterinary Products
Health Care Services
Net SalesSept 2016
Rp13.940,16 billion
11
*Growth of net sales per products as describe below :
BUSINESS OVERVIEW
ALL BUSINESS LINE OF THE COMPANY WERE GREW SIGNIFICANTLY
Products Portfolio Net Sales Sept 2015 (Rp) Net Sales Sept 2016 (Rp) Growth %
Consumer Products 5.477.810.550.954 6.070.637.256.423 10,82
Prescription Medicine 3.540.808.364.310 3.743.517.742.077 5,72
Non Prescription Medicine 2.058.306.118.876 2.259.833.128.339 9,79
Raw Materials for Sale 989.095.275.150 1.056.189.703.284 6,78
Medical Equipment 572.000.184.366 779.445.923.756 36,27
Veterinary Products 27.482.534.354 25.197.432.294 (8,31)
Health Care Services 4.823.897.355 5.335.782.616 10,61
Total : 12.670.326.925.365 13.940.156.968.789 10,02
12
Total NetSales
ConsumerProducts
PrescriptionMedicine
NonPrescription
Medicine
Raw Materialsfor Sale
MedicalEquipment
VeterinaryProducts
Health CareServices
2015 2016
5.72 %9.79 %
6.78 %36.27 %
BUSINESS OVERVIEW
GROWTH OF NET SALES SEPT 2015 VS SEPT 2016
10,02%
(8.31) %10.61 %
10.82 %
13
BUSINESS OVERVIEW
THE COMPANY’S PRINCIPALS
Non-Prescription
Prescription
Consumer – Health – Beauty
14
BUSINESS OVERVIEW
THE COMPANY’S PRINCIPALS
Medical Device & Diagnostic
15
BUSINESS OVERVIEW
THE COMPANY’S PRINCIPALS
Raw material
16
RDC JAKARTARDC SURABAYA46 BRANCH27 BRANCH under subsidiaries (TSJ)30 SALES OFFICE
BUSINESS OVERVIEWNATIONAL COVERAGE 73 FULL SERVICES BRANCHES & MORE THAN 200,000 DIRECT OUTLET COVERAGE
17
Type of outlet coveraged by the company’s distribution
Covers all trade channels in the market :
BUSINESS OVERVIEW
MORE THAN 200,000 DIRECT OUTLET COVERAGE
General / Traditional Trade Channel
• Wholesalers
• Retailers
• Provision Stores
• Convenience Stores
• Food & Beverage
• Store - Fruit Shops
• Cosmetic Stores
• etc
Modern Trade Channel
• Hypermarkets
• Supermarkets
• Mini Markets
• Departement Stores
• etc
Pharmaceutical Trade Channel
• Pharmacies
• Drugstores
• Hospitals
• Labs – Clinics
• Institutions
• etc
18
2016 OVERVIEW
SALES CONTRIBUTION BY CHANNEL (Sept 2015 VS Sept 2016)
43,30%
35,83%
20,88%
2016
Pharmaceutical Trade General Trade
Modern Trade
42,38%
34,59%
23,03%
2015
Pharmaceutical Trade General Trade
Modern Trade
19
2016 OVERVIEW
SALES CONTRIBUTION BY PRINCIPAL (Sept 2015 VS Sept 2016)
19%
81%
2015
External Principal Internal Principal
14%
86%
2016
External Principal Internal Principal
20
BUSINESS OVERVIEW
THE COMPANY’S MODERN TRADE ACCOUNT
21
BUSINESS OVERVIEW
200,000+ DIRECT OUTLET COVERAGE
Pharmacy; 11.571
Hospital; 1.614
Drugstore; 4.485
Wholesaler; 2.260
Hypermarket, 178
Supermarket; 1.179
Minimarket; 3.115
Provision Store; 162.000
F&B Stores; 15.000
Cosmetics; 1.750
Others; 9.800
Covers all trade channels in the market:
- General / Traditional Trade Channel: Wholesalers, Retailers, Provision Stores, Convenience Stores, Food & Beverage Stores, Fruit Shops, Cosmetics Stores, etc
- Modern Trade Channel: Hypermarkets, Supermarkets, Mini Markets, Department Stores, etc
- Ethical Trade Channel: Pharmacies, Drugstores, Hospitals, Labs - Clinics, Institutions, etc
22
SECTION 3OPERATIONAL OVERVIEW
OPERATIONAL OVERVIEW
Mobile application (Tablet Computer & PDA)
- Supervisor: Team Performance Analysis.
- Salesman & Deliveryman: Faster Order Taking & Faster Information Process.
Global Information System (GIS)
- Application for more in depth sales and territory mapping.
Supported by Enseval Customer Care (ECC) – HOTLINE 1500095
In Branches Order Management, Complaint Handling, Basic Product Information.
Customers also can reach Enseval office via Phone, Fax & Email for easy customer ordering.
IT INFRASTRUCTURE
26
OPERATIONAL OVERVIEW
Centralized IT system using Oracle E-Business Solutions• Integrated & Real Time system
Use the best world-class ERP system by Oracle Complete Oracle E-Business SuiteOracle Warehouse Management System (WMS)Advance Supply Chain Planning (ASCP) and Oracle Demantra
Tablet Computer & PDA system E-Mobile ®2,300+ PDA used by Supervisors, Salesmen, Deliverymen, & Collectors Menu: Distribution Plan, Distribution Achievement, Overdue, etc
Provide data security for antivirus by Trend Micro and Sonic Wall
IT INFRASTRUCTURE
27
OPERATIONAL OVERVIEW
• ENI (Enseval Net Info) • Web based application
• Sales (hourly updated) & Stock (D-1)
• EXI (Enseval Xpress Info)• SMS based application
• Sales & Stock Report
• ERI (Enseval Raw Data Info)• Raw Data format, distribution and logistics information activities
• ENO (Enseval NET Order)
• EMOS (Enseval Mobile Order System)
• Online order with business-to-business system
For Principal
For Customer
COMPREHENSIVE BUSINESS ACCESS
28
SECTION 4FINANCIAL OVERVIEW
FINANCIAL OVERVIEW
NET SALES GROWTH
12.670,33 11.147,0713.940,16 12.395,13
2015 2016
87,98%88,92%
0,94%
10,02%
11,20%
: Net Sales in Rp/billion : COGS in Rp/billion
: Net Sales in Rp/billion : COGS in Rp/billion
: COGS Margin
Net Sales COGS
Sept 30, 2015 (Unaudited)
Sept 30, 2016 (Unaudited)
Sept 30, 2015 (Unaudited)
Sept 30, 2016 (Unaudited)
30
1.523,25
1.545,02
FINANCIAL OVERVIEW
EXPENSE RATIO
1,43%
Sept 30, 2015 (Unaudited)
Sept 30, 2016 (Unaudited)
Gross Profit
Gross Profit Margin
Gross Profit (Rp/billion)
12,02%11,08%
(0,94%)
1.008,42
1.105,20
9,60%
Sept 30, 2015 (Unaudited)
Sept 30, 2016 (Unaudited)
Operational Expense
Operational Expense Margin
Operational Expense (Rp/billion)
7,96%7,93%
(0,03%)
31
FINANCIAL OVERVIEW
PROFIT GROWTH (Sept 2015 VS Sept 2016)
514,83 524,40388,30439,82 496,21
377,10
(14,57%) (5,38%)
(2,89%)
Operating Profit Margin Income Before Tax Expense Margin
Income For The Period Margin
Sept 30, 2015 (Unaudited)
Sept 30, 2016 (Unaudited)
Sept 30, 2015 (Unaudited)
Sept 30, 2016 (Unaudited)
Sept 30, 2015 (Unaudited)
Sept 30, 2016 (Unaudited)
4,06% 3,16%(0,91%)
Operating Profit(Rp/billion)
Income Before Tax Expense (Rp/billion)
Operating Profit Income BeforeIncome Tax Expense
Income For The Period
4,14% 3,56%(0,58%)3,06% 2,71%
(0,36%)
32
FINANCIAL OVERVIEW
FINANCIAL POSITION (Dec 2015 VS Sept 2016)
6.747,94
2.677,704.070,25
7.095,00
2.649,144.445,86
5,14%
(1,07%)
9,23%
Dec 31, 2015 (Audited)
Sept 30, 2016 (Unaudited)
Total Assets (Rp/billion) Total Liabilities (Rp/billion)
Dec 31, 2015 (Audited)
Sept 30, 2016 (Unaudited)
Dec 31, 2015 (Audited)
Sept 30, 2016 (Unaudited)
33
SECTION 52016 OVERVIEW
WAREHOUSE MANAGEMENT SYSTEM-Oracle-based WMS
-Manage stock from
inbound-outbound, by location, SKU, Batch Number, Expiry Date.
-Bar-coding system with mobile bar-code reader to eliminate duplication & increase accurate operation.
35
COLD CHAIN MANAGEMENT-Enseval has implemented and Standardized Cold Chain Management in it’s RDC, Branch Warehouse, and Transportation according to ISO 9001:2008.
-Cold Chain Management is performed with close control
-All activities is always recorded and stored properly
Cold Chain Handling in Enseval Delivery with Temperature Controlled Transportation
Temperature MonitoringDocument
36
STANDARDIZED FACILITIESSTANDARDIZED BRANCHES (FULL SERVICES)
37
STRATEGIC VALUE TO BUSINESS PARTNERS• Strong product portfolio.
• Sustainable business growth.
• Supported by 2 RDC, 46 branches, 30 Sales Office, & 200,000+ direct coverage outlets.
Market Leading Position in Indonesia
• 40+ years of strategic expertise in distribution and logistics service.
• Strong and good relationship with all business players : Principals & Outlets.
• Having in aggregate over 100 years of experience senior management team and supported by more than 5,700 employees.
Reliable Partner to Grow
• Public listed company with professional management that treats all business partners equally with the utmost transparency and accountability.
• Independent business entity with neutrality to ensure fairness to all stakeholders.Transparency and Neutrality
• Robust balance sheet figures.
• Solid financial performance.Strong Financial Track Record
• Commitment to assist & support Principal to achieve it’s goals.
• Implementation of Continuous Improvement (CONIM) in all business aspects by Enseval’s employees in every level.
Enseval’s Commitment Towards Improvement
38
FORWARD LOOKING STATEMENTThis presentation has been prepared for informational purposes only by PT Enseval Putera Megatrading Tbk. ("Enseval" or the "Company")
This presentation has been prepared solely for use in connection with the release 0f 30 Sept 2016 (unaudited) results of the Company. The informationcontained in this presentation has not been independently verified. No representation, warranty or undertaking, express or implied, is made as to, and noreliance should be placed on, the fairness, accuracy, completeness or correctness of the information or the opinions contained herein. None of the Company orany of their respective affiliates, and their respective commissioners, directors and employees, advisors or representative shall have any liability whatsoever (innegligence or otherwise) for any loss however arising from any use of this presentation or its contents or otherwise arising in connection with the presentation.Any decision to purchase or subscribe for securities of the Company should not be made on the basis of the information contained in this presentation.The presentation is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or anexemption from registration.This presentation and its contents are confidential unless they are become generally avaiable as public information in accordance with prevailing lawsregulations (other than as a result of a disclosure by you) and must not be distributed, published or reproduced (in whole or in part) or disclosed by receipentsto any other person. This presentation does not constitute a recommendation regarding the securities of the Company.This presentation, including the information and opinions contained herein, is provided as the date of this presentation and is subject to change without notice,including change as a result of the issuance of 30 Sept 2016 unaudited results of the Company.This presentation includes "forward-looking statements". These statements contain the words "anticipate", "believe", "intend", "estimate", "expect" and wordsof similiar meaning. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding theCompany's financial position, business strategy, plans and objectives of management for future operations (including development plans, objectives relating tothe Company's products and services and anticipated product launches) are forward-looking statements. Such forward-looking statements are based onnumerous assumptions regarding the Company's present and future business strategies and the environment in which of the Company will operate in thefuture. These forward-looking statements speak only ast the date of this presentation. The Company expressly disclaims any obligation or reflection of anychange in the Company's expectations with regard thereto, or any change in events, conditions or circumtances on which any statements is based.Market data and certain industry forecast used in this presentation were obtained from market research, publicity avaiable information and industrypublications which have not been independently verified, and no presentation is made as to the accuracy of such information.
THANK YOUFor Further Information:
Corporate SecretaryPT Enseval Putera Megatrading Tbk.Enseval BuildingKawasan Industri PulogadungJalan Pulolentut No. 10Jakarta 13920 – IndonesiaPhone : 62-21-46822422 Fax : 62-21-4609039Website : www.enseval.comEmail : [email protected]
